Together, these findings suggest that early PRDM9-dependent H3K4me3 is critical for the survival of persister cells, whereas the subsequent removal of this mark - either through demethylation by KDM5 or histone cleavage by CTSL1 - is not a vulnerability of glioblastoma persister cells. Here, PRDM9 is linked to glioblastoma.